Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2014/497178 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832549859160227840 |
---|---|
author | David R. Griffin Preston P. Richmond John C. Olson |
author_facet | David R. Griffin Preston P. Richmond John C. Olson |
author_sort | David R. Griffin |
collection | DOAJ |
format | Article |
id | doaj-art-6b6e228a14c14ba1b1aeced975d67bc5 |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-6b6e228a14c14ba1b1aeced975d67bc52025-02-03T06:08:26ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/497178497178Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular DegenerationDavid R. Griffin0Preston P. Richmond1John C. Olson2The University of Central Florida College of Medicine, 6850 Lake Nona Boulevard, Orlando, FL 32827, USACentral Florida Retina and the Macular Degeneration Center, 44 Lake Beauty Drive, Suite 300, Orlando, FL 32806, USACentral Florida Retina and the Macular Degeneration Center, 44 Lake Beauty Drive, Suite 300, Orlando, FL 32806, USAhttp://dx.doi.org/10.1155/2014/497178 |
spellingShingle | David R. Griffin Preston P. Richmond John C. Olson Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration Journal of Ophthalmology |
title | Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration |
title_full | Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration |
title_fullStr | Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration |
title_full_unstemmed | Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration |
title_short | Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration |
title_sort | intravitreal aflibercept outcomes in patients with persistent macular exudate previously treated with bevacizumab and or ranibizumab for neovascular age related macular degeneration |
url | http://dx.doi.org/10.1155/2014/497178 |
work_keys_str_mv | AT davidrgriffin intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration AT prestonprichmond intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration AT johncolson intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration |